# Network Pharmacology-Based Characterization of Mecasin (KCHO-1) as a Multi-Target Modulator of Neuroinflammatory Pathways in Alzheimer’s Disease

## TL;DR

This study explores how Mecasin, a multi-herb formulation, may affect Alzheimer's disease by targeting multiple genes and pathways involved in neuroinflammation.

## Contribution

The study introduces a network pharmacology framework to characterize Mecasin as a multi-target modulator in Alzheimer's disease.

## Key findings

- Six core genes (AKT1, STAT3, IL6, TNF, EGFR, IL1B) were identified as central to Mecasin's interaction with AD-related pathways.
- Molecular docking suggests Mecasin compounds may bind to targets like AKT1 and TNF.
- Mecasin's multi-component nature allows broad compound–target associations in neuroimmune pathways.

## Abstract

Background/Objectives: Mecasin (KCHO-1) is a standardized multi-herb formulation containing diverse bioactive compounds predicted to engage multiple molecular targets. This study applied an integrative network pharmacology approach to explore how Mecasin may interact with Alzheimer’s disease (AD)-related molecular networks. Methods: Bioactive constituents from 9 herbs were screened through OASIS and PubChem, and their predicted targets were cross-referenced with 8886 AD-associated genes from GeneCards. Overlapping genes were analyzed using protein–protein interaction mapping, Gene Ontology, and KEGG to identify potential Mecasin–AD core nodes and pathways. Co-expression, co-regulation, and molecular docking analyses were performed to further characterize mechanistic relevance. Results: Network integration identified 6 core genes—AKT1, STAT3, IL6, TNF, EGFR, and IL1B—positioned within signaling pathways related to neuronal survival, inflammatory regulation, and cellular stress responses, including FoxO, JAK–STAT, MAPK, and TNF pathways. Molecular docking suggested that several Mecasin compounds may interact with targets such as AKT1 and TNF. Conclusions: These in silico findings indicate that Mecasin, a multi-component formulation containing numerous phytochemicals that generate broad compound–target associations, may interface with interconnected neuroimmune pathways relevant to AD. While exploratory, the results highlight potential multi-target mechanisms that merit further investigation and provide a systems-level framework to inform future experimental validation.